3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
13
Glioblastoma
7
Glioma
5
Epilepsy
5
Stroke
3
Pheochromocytoma
3
Parkinson Disease
3
Paraganglioma
3
Neuroblastoma
3
Neoplasms
3
Speech
2
Neurofibromatosis 1
2
Neurofibroma
2
Multiple Sclerosis
2
Migraine Disorders
2
Lung Neoplasms
2
Diabetes Mellitus
2
Carcinoma, Non-Small-Cell Lung
2
Amyotrophic Lateral Sclerosis
2
Adrenal Gland Neoplasms
2
Tinnitus
1
Thyroid Neoplasms
1
Tension-Type Headache
1
Stress Disorders, Post-Traumatic
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Stenosis
1
Spinal Cord Injuries
1
Skin Neoplasms
1
Restless Legs Syndrome
1
Renal Insufficiency, Chronic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Muscular Diseases
×
CNS
×
Clear all
NCT05116137
2026-05-29
RESIST
Nova Scotia Health Authority
Phase NA
Enrolling by invitation
24 enrolled